Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 213

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer

Burkhardt, Lia, Fuchs, Sarah, Krohn, Antje, Masser, Sawinee, Mader, Malte, Kluth, Martina, Bachmann, Frederik, Huland, Hartwig, Steuber, Thomas, Graefen, Markus, Schlomm, Thorsten, Minner, Sarah, Sauter, Guido, Sirma, Hüseyin, Simon, Ronald·2013·Cancer Research

Abstract

Deletions involving the chromosomal band 5q21 are among the most frequent alterations in prostate cancer. Using single-nucleotide polymorphism (SNP) arrays, we mapped a 1.3 megabase minimally deleted region including only the repulsive guidance molecule B (RGMB) and chromodomain helicase DNA-binding protein 1 (CHD1) genes. Functional analyses showed that CHD1 is an essential tumor suppressor. FISH analysis of 2,093 prostate cancers revealed a strong association between CHD1 deletion, prostate-specific antigen (PSA) biochemical failure (P = 0.0038), and absence of ERG fusion (P < 0.0001). We found that inactivation of CHD1 in vitro prevents formation of ERG rearrangements due to impairment of androgen receptor (AR)-dependent transcription, a prerequisite for ERG translocation. CHD1 is required for efficient recruitment of AR to responsive promoters and regulates expression of known AR-responsive tumor suppressor genes, including NKX3-1, FOXO1, and PPARγ. Our study establishes CHD1 as the 5q21 tumor suppressor gene in prostate cancer and shows a key role of this chromatin remodeling factor in prostate cancer biology. Cancer Res; 73(9); 2795–805. ©2013 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-12-1342

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 213

Metadata

Authors
Burkhardt, L., Fuchs, S., Krohn, A., Masser, S., Mader, M., Kluth, M., Bachmann, F., Huland, H., Steuber, T., Graefen, M., Schlomm, T., Minner, S., Sauter, G., Sirma, H., & Simon, R.
Venue
Cancer Research
Published
2013-04-30
Volume
73
Issue
9
Pages
2795-2805
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2172123503
Cited by
213
References
5
FWCI
19.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-12-1342
The paper
Burkhardt, L., Fuchs, S., Krohn, A., Masser, S., Mader, M., Kluth, M., Bachmann, F., Huland, H., Steuber, T., Graefen, M., Schlomm, T., Minner, S., Sauter, G., Sirma, H., & Simon, R. (2013). CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-12-1342

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.